Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07226661 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Name: Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder — clinical trial record (NCT07226661)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorSupernus Pharmaceuticals, Inc.

Started2026-01-19

View on ClinicalTrials.gov ↗

Amendment history

2026-03-19

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2026-01-01→confirmed 2026-01-19

Study sitesdetails revised at 1 of 1 site

2025-11-07

Original filing

Supernus Pharmaceuticals, Inc.

10 trials monitored

See 1 trial at risk

Depression

2,976 trials monitored

See 162 trials at risk

This study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder

Trial Details

NCT Number	NCT07226661
Lead Sponsor	Supernus Pharmaceuticals, Inc.
Conditions	Major Depressive Disorder (MDD)
Enrollment	230 participants
Start Date	2026-01-19
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-24